MedTrace Logo

Prediction of Functional Recovery in Patients With Intracerebral Hemorrhage

NCT07728734 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1688

Last updated 2026-07-28

No results posted yet for this study

Summary

Currently, we lack sufficiently reliable tools to accurately predict, in the first few hours, the vital prognosis, functional status, and quality of life of patients with intracerebral hemorrhage (ICH). With new neurosurgical techniques and improvements in neurocritical care, it is essential to adapt therapeutic decisions to the wishes of patients and their families. Doing so based on a reliable functional prognosis will reduce arbitrariness in treatments and help avoid situations of unwanted dependency and high social and healthcare costs.

This project aims to validate, in several hospitals in Spain and in real-world clinical practice, a new, easy-to-implement predictive scale that estimates the probability of functional recovery in patients with ICH in the short and long term. It will also analyze new prognostic blood biomarkers that could enhance the scale's accuracy.

Conditions

  • Intracranial Hemorrhage, Spontaneous

Interventions

OTHER

CLINICAL SCORE TO PREDICT FUNCTIONAL OUTCOME

No other interventions

OTHER

Variables necessary for calculating the score under study (PRO-ICH) will be collected, as well as baseline and 60-120 minutes after baseline of serum blood samples

No other interventions

Sponsors & Collaborators

  • Germans Trias i Pujol Hospital

    lead OTHER

Principal Investigators

  • MÒNICA MILLÁN, MD · Germans Trias i Pujol Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2029-07-31
Completion
2029-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07728734 on ClinicalTrials.gov